This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Mary L. Wagner, PharmD; Ron Preblick, RPh
Department of Pharmacy Practice and Administration William Levine Hall Busch Campus PO Box 789 Piscataway, NJ 08855-0789

Arch Neurol. 1994;51(8):748-749.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We commend Isojärvi et al¹ for their article, "Serum Lipid Levels During Carbamazepine Medication: A Prospective Study." This study should greatly contribute to the medical literature, but we are concerned that some of the conclusions are misleading because of their inappropriate statistical analyses. Since multiple comparisons were made using the t test (at baseline, after 2 months, and after 1 year),¹ there is an increased risk of making a type I error.² In other words, the chance of finding a significant difference when one is actually not present is increased. An analysis of variance for repeated measures with a posthoc test would have been more appropriate in analyzing statistical significance.³ With the lack of patient-specific data, we cannot reassess the results for significance using this method, but a Bonferroni correction can be used to decrease the chance of making a type I error when multiple comparisons . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?